Cellectis Change In Cash from 2010 to 2025

CLLS Stock  USD 1.31  0.01  0.77%   
Cellectis Change In Cash yearly trend continues to be comparatively stable with very little volatility. Change In Cash is likely to outpace its year average in 2025. From the period from 2010 to 2025, Cellectis Change In Cash quarterly data regression had mean square error of 9837.1 T and mean deviation of  71,838,925. View All Fundamentals
 
Change In Cash  
First Reported
2012-09-30
Previous Quarter
10 M
Current Value
-15.8 M
Quarterly Volatility
54.8 M
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.8 M, Interest Expense of 7.8 M or Selling General Administrative of 29.7 M, as well as many indicators such as Price To Sales Ratio of 3.47, Dividend Yield of 0.0 or PTB Ratio of 1.1. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Cellectis SA over the last few years. It is Cellectis' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Pretty Stable
   Change In Cash   
       Timeline  

Cellectis Change In Cash Regression Statistics

Arithmetic Mean10,884,622
Coefficient Of Variation904.39
Mean Deviation71,838,925
Median6,543,000
Standard Deviation98,439,713
Sample Variance9690.4T
Range331.7M
R-Value(0.23)
Mean Square Error9837.1T
R-Squared0.05
Significance0.39
Slope(4,739,177)
Total Sum of Squares145355.7T

Cellectis Change In Cash History

20257.4 M
20246.5 M
202343.5 M
2022-92.4 M
2021-55.5 M
2020-99.4 M
2019-111 M

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash6.5 M7.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.